|
Volumn 53, Issue 2, 2005, Pages 284-290
|
Botulinum toxin type A
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
ACETYLSALICYLIC ACID;
ALPHA TOCOPHEROL;
BOTULINUM TOXIN A;
BOTULINUM TOXIN B;
COLLAGEN IMPLANT;
NEUROTOXIN;
NEUTRALIZING ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
SYNAPTOBREVIN;
ACETYLCHOLINE RELEASE;
BLEPHAROSPASM;
CLINICAL TRIAL;
CLOSTRIDIUM BOTULINUM;
DIPLOPIA;
DRUG EFFICACY;
DRUG SAFETY;
DRY EYE;
DYSTONIA;
ECCHYMOSIS;
EDEMA;
EYE DISEASE;
EYEBROW;
FLU LIKE SYNDROME;
HEADACHE;
HEMATOMA;
HEMIFACIAL SPASM;
HUMAN;
HYPERHIDROSIS;
MIGRAINE;
MUSCLE CONTRACTION;
MUSCLE WEAKNESS;
NEUROMUSCULAR BLOCKING;
NEUROTRANSMISSION;
NONHUMAN;
OSTEOLYSIS;
PAIN;
PRIORITY JOURNAL;
PTOSIS;
REVIEW;
RHYTIDOPLASTY;
SIDE EFFECT;
STRABISMUS;
SURGICAL TECHNIQUE;
TENSION HEADACHE;
BOTULINUM TOXIN TYPE A;
COSMETIC TECHNIQUES;
HUMANS;
|
EID: 22144474038
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2005.03.060 Document Type: Review |
Times cited : (43)
|
References (0)
|